- FemCerv® is the first endocervical tissue sampler designed to collect and contain a comprehensive sample to maximize quality and…
BOSTON, May 03, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel…
DEERFIELD, Ill., May 03, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on…
HOUSTON, May 03, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a leading T-cell receptor…
MIAMI, FL, May 03, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and CompaniesVANCOUVER, British Columbia, May 03, 2023…
Unveils New Investor Presentation on WebsiteMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, May 03, 2023 (GLOBE NEWSWIRE) -- ReWalk…
DURHAM, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in…
BERKELEY HEIGHTS, N.J., May 03, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…
- Transaction values Avertix at an enterprise value of $195 million- Avertix developed the Guardian™ System, the first and only…